Skip to main content
. Author manuscript; available in PMC: 2017 Sep 12.
Published in final edited form as: Pancreas. 2017 Feb;46(2):151–156. doi: 10.1097/MPA.0000000000000734

Table 2.

Median (25th – 75th percentile), overall survival (OS) from diagnosis, overall survival from the first PRRT and time to progression (TTP) by site (all survival values in months).

Site Overall survival
from diagnosis date		 Overall survival
from the first PRRT		 Time to progression
from the first PRRT
All Sites 122.7 (58.7 – 223.1) 40.0 (18.5–97.7) 23.9 (11.0–60.8)
SBNETs 199.3 (117.2 – 265.9) 95.4 (18.6–>118.8) 27.2 (17.4–83.5)
PNETs 68.4 (49.6 – 142.7) 37.3 (18.1–48.0) 37.0 (6.5–48.0)
Lung 143.3 (52.1 – >191.2) 32.4 (18.4–>137.6) 18.6 (7.5–61.9)
Unknown primary 64.5 (29.8–89.2) 20.4 (17.2–29.2) 20.0 (10.6–29.2)
Other 85.5 (72.4–216.4) 55.9 (40.0–88.9) 13.7 (11.0–43.4)